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PURPOSE. Evidence from human myopia genetic mapping stud-
ies (MYP3 locus), modulated animal models, and observations
of glycemic control in humans suggests that insulin-like growth
factor (IGF)-1 plays a role in the control of eye growth. This
study was conducted to determine whether IGF-1 polymor-
phisms are associated with myopia in a large, international
dataset of Caucasian high-grade myopia pedigrees.
METHODS. Two hundred sixty-five multiplex families with 1391
subjects participated in the study. IGF-1 genotyping was per-
formed with 13 selected tag single nucleotide polymorphisms
(SNPs) using allelic discrimination assays. A family-based pedigree
disequilibrium test (PDT) was performed to test for association.
Myopia status was defined using sphere (SPH) or spherical equiv-
alent (SE), and analyses assessed the association of (1) high-grade
myopia (5.00 D), and (2) any myopia (0.50 D) with IGF-1
markers. Results were declared significant at P  0.0038 after
Bonferroni correction. Q values that take into account multiple
testing were also obtained.
RESULTS. In all, three SNPs—rs10860860, rs2946834, and
rs6214—were present at P  0.05. SNP rs6214 showed posi-
tive association with both the high-grade– and any-myopia
groups (P  2  103 and P  2  103, respectively) after
correction for multiple testing.
CONCLUSIONS. The study supports a genetic association between
IGF-1 and high-grade myopia. These findings are in line with
recent evidence in an experimental myopia model showing that
IGF-1 promotes ocular growth and axial myopia. IGF-1 may be a
myopia candidate gene for further investigation. (Invest Ophthal-
mol Vis Sci. 2010;51:4476–4479) DOI:10.1167/iovs.09-4912
Myopia is the most common eye disorder, affecting approx-imately one third of the population older than 12 years in
the United States.1 The public health impact, along with the
associated costs of optical correction, is substantial.2,3 High-
grade myopia can increase the risk of cataract, glaucoma,
retinal detachment, and chorioretinal degeneration.4 The eti-
ology of myopia is not fully understood, but both genetic and
environmental factors are believed to be involved in its devel-
opment and progression. Several genetic mapping studies have
been performed to identify cytogenetic susceptibility regions
for myopia,5 and research is ongoing to identify causative
genes involved in myopia development and progression.
Insulin-like growth factor (IGF)-1 is a polypeptide that plays an
important role in cell proliferation, differentiation, and apoptosis.
Evidence from human genetic mapping studies, experimental
myopia induction in animal models, and observations of an asso-
ciation between poor glycemic control and myopia in humans
suggests that IGF-1 also has a role in controlling eye growth.
Before the present study, we had mapped a novel autoso-
mal dominant high-grade myopia locus (MYP3; OMIM 603221;
Online Mendelian Inheritance in Man; http://www.ncbi.
nlm.nih.gov/Omim/ provided in the public domain by the
National Center for Biotechnology Information, Bethesda, MD)
to the long arm of chromosome 12, region 21-23, in a large
German/Italian family.6 Linkage analysis in a cohort of 51 U.K.
families suggested that the MYP3 locus could be responsible
for high myopia in approximately 25% of the families.7 More
recently, the MYP3 locus was replicated by our group with a
whole-genome linkage scan involving 254 families with high-
grade myopia from the Myopia International Consortium8 and
by Nurnberg et al.9 in a large, six-generation German kindred.
IGF-1 maps to 12q23.2 and lies within the MYP3 locus.
In two independent studies published recently, the chick
model of experimental myopia showed accelerated ocular
growth after intravitreal injections of insulin or IGF-1, suggest-
ing that these molecules are powerful stimulators of axial
myopia.10,11 Furthermore, the receptor expression levels for
the IGF-1 gene in the chick model were upregulated in the
retinal pigment epithelial layer during experimental myopia
induction (10-D lens treatment; Zhang Z, et al. IOVS 2007;
48:ARVO E-Abstract 4417).
Cordain et al.12 speculated that high-glycemic-load carbohy-
drate diets may contribute to the development and progression
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of myopia, perhaps by affecting sensitivity to insulin or increas-
ing free-circulating IGF-1 levels. This hypothesis is supported
by a retrospective study that revealed poor metabolic control
of glucose to be a risk factor for myopia.13 Also, in patients
with primary growth hormone insensitivity, IGF-1 is an impor-
tant regulator of ocular growth.14 It should be noted that the
specific role of IGF-1 in myopigenesis in the context of glyce-
mic control is currently unknown and remains to be investi-
gated in epidemiologic studies.
The role of IGF-1 gene polymorphisms in association with
human myopia has not been investigated to date. Therefore, we
ascertained a large Caucasian cohort biased toward high-grade
myopia and performed genetic association analyses of polymor-
phisms of IGF-1 with myopia refractive error phenotypes.
MATERIALS AND METHODS
Subject Selection
Informed consent was acquired from all subjects before they entered
the study, and the principles of the Declaration of Helsinki were
followed. The study was approved by the Institutional Review Board at
the Duke University Medical Center (Durham, NC). High-grade myopia
status was assigned to sphere (SPH) or spherical equivalent (SE) refrac-
tive error [defined by sphere  (cylinder/2)] of 5.00 D or more in at
least one eye. Families were eligible for inclusion if they had one
member with high-grade myopia, and all available family members
were recruited. Complete ophthalmic examinations were performed,
including cycloplegic retinoscopy and/or autorefraction (model RM-
8800; Topcon Medical Systems, Inc., Paramus, NJ). Refractions were
recorded in positive cylinder format, and manifest refraction data were
used in the analyses. Patients with systemic conditions, syndromic disor-
ders, or ophthalmic conditions that could predispose to high myopia were
excluded. A total of 265 multiplex high-grade myopia Caucasian families that
included 1391 subjects participated in the study; the sample encompassed all
families from the International Myopia Consortium.8 Of these, 153 families
were ascertained in the United States (Duke University), 46 in the United
Kingdom (Cardiff University), 25 in Denmark (National Eye Clinic, Kennedy
Institute), 1 inAustralia (University ofMelbourne), and 40 in France (Toulouse
University).
Marker Selection and Genotyping
The SNPSelector program15 was used to choose tagging SNPs that
met the criteria of a Pearson-squared correlation (r2) threshold of 0.67
in the linkage disequilibrium bins and a minor allele frequency (MAF)
greater than 5% in the HapMap CEU population. Thirteen tag SNPs
were selected, to provide full gene coverage. The SNPs chosen for the
candidate gene are shown in Figure 1.
After venous blood sample collection, total genomic DNA was
extracted (AutoPure LS DNA Extractor and Puregene reagents; Gentra
Systems Inc; Minneapolis, MN). For genotyping reactions, custom
allelic discrimination assays were performed (TaqMan; Applied Biosys-
tems [ABI], Foster City, CA), consisting of unlabeled polymerase chain
reaction (PCR) primers and the minor groove binding (MGB) group
probes (TaqMan FAM and VIC dye-labeled; ABI). The assays comprised
two unlabeled PCR primers and two allele-specific probes. PCR reac-
tions were then performed (Taqman Universal PCR Master Mix, Gene-
Amp PCR System 9700; ABI), and the allelic discrimination calls were
read (7900HT Fast PCR System; ABI).
All 1391 subjects who participated in the study were genotyped.
For quality control purposes, two CEPH (Centre d’Etude du Polymor-
phisme Humain) DNA standards were included in each 96-well plate,
and two blind duplicate samples were used per plate. Genotype sub-
mission to the analysis database required 100% matching quality con-
trol genotypes within and across plates and with at least 95% genotyp-
ing efficiency. All genotypes were in Hardy-Weinberg equilibrium
(HWE). Two datasets with unrelated samples were formed in which
one affected individual sample per family was randomly selected to
cluster within a designated affected group, and one unaffected indi-
FIGURE 1. Representation of the 13
SNPs selected for the IGF-1 gene
(source; Human Genome Browser
(http://genome.ucsc.edu/ provided
in the public domain by UCSC Ge-
nome Bioinformatics, University of
California at Santa Cruz). The Hap-
Map linkage disequilibrium map for
the region for European samples
from the CEPH (30 trios) is also dis-
played.
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vidual sample per family was selected to add to a designated unaffected
group. An exact test implemented in the Genetic Data Analysis (GDA)
program was used to test HWE in which 3200 permutations were
performed to estimate the empiric P value for each marker.16
Statistical Analyses
Analyses assessed the following myopic refractive error phenotypes (1)
high myopia (5.0D), and (2) any myopia (0.5D). The pheno-
types were based on either SPH or SE. The dataset was stratified in this
manner to investigate the effect of genetic background on common
myopia within this cohort. It is notable that more than 85% of the
cohort was older than 20 years (an age by which refractive state
becomes relatively stable). The family-based pedigree disequilibrium
test (PDT)17 was performed to test the association of IGF-1 polymor-
phisms with each myopia phenotype state. After Bonferroni correction
for multiple testing, statistical significance was defined as P  0.0038
(0.05/13). Although we did not account for the multiple phenotypes
tested to set this threshold, the somewhat less-stringent Bonferroni
correction is justified, because the phenotypes studied are noninde-
pendent. We also used a less conservative multiple-correction method
for a comparison, for which we obtained q-values for all markers with the
Q-Value program (http://faculty.washington.edu/jstorey/qvalue/).18 This
program converts the P value to a q value at a marker, where q value
is the estimate of the proportion of false positives incurred (false-
discovery rate) when the marker is called significant.
RESULTS
The number of affected and unaffected subjects for each clas-
sification is described in detail in Table 1. Table 2 depicts
clinical information for the dataset based on SPH classifica-
tions. Among 13 IGF-1 SNPs tested, three SNPs—rs10860860,
rs2946834, and rs6214—showed P  0.05. The SNP rs6214
showed significant association with the high-grade– and any-
myopia groups (P  2  103, q  0.08) after correction for
multiple testing. The positive association was consistent with
analyses performed on SPH and SE phenotypes. Table 3 pro-
vides the P values (PDT) for all the polymorphisms tested.
DISCUSSION
IGF-1 has been a target candidate gene of genetic association
studies for numerous human diseases and characteristics such as
diabetes, diabetic retinopathy (DR), cancer susceptibility, osteo-
arthritis, body weight, growth, menarche, and longevity.19 It has
been implicated in ocular diseases such as proliferative DR,
retinopathy of prematurity (ROP), and age-related macular de-
generation (AMD).20–24 In the present study, IGF-1 polymor-
phisms were tested for possible association with myopia and
the SNP rs6214 showed significant association with the high-
grade– and any-myopia phenotypes.
The SNP rs6214 is located in the 3-untranslated region
(UTR) of the IGF-1 gene. The minor allele frequencies in
European, Han Chinese, Japanese, and Yoruba populations are
0.421, 0.467, 0.568, and 0.533, respectively, based on HapMap
data (www.hapmap.org). 3-UTR variants may play an impor-
tant role in disease by regulating gene expression, as 3 regu-
latory regions control mRNA 3 end formation, stability, nu-
clear export, subcellular localization, and translation.25,26 The
association of IGF-1 with high-grade myopia may be due to a
similar mechanism involving regulation of gene expression
levels. Arends et al.27 hypothesized that minor genetic varia-
tion in the IGF-1 gene could influence pre- and postnatal
growth. Thus, the speculation that IGF-1 may also influence
ocular growth is in line with the findings that body size param-
eters can predict eye size to a large extent, indicating common
genetic influences on both body and eye growth.28 However,
it should be noted that the referenced study reports findings
from a breeding experiment in chickens, and it is unclear
whether such findings would translate to mammals or humans.
It is more than likely that a functional polymorphism that is
in strong LD with rs6214 may be involved in myopia. Although
we did not observe any stronger association with other IGF-1
SNPs, genes centromeric to IGF-1, which include nucleoporin
37 kDa (NUP37), coiled-coil domain containing 53 (CCDC53),
promelanin-concentrating hormone (PMCH), and hypothetical
protein LOC55010 (C12orf48), are not obvious candidates and
are only in modest LD with the IGF-1 gene (based on HapMap
CEU population data). Although the exact role of IGF-1 in
TABLE 1. Summary of Number of Subjects across Various Phenotype Classifications in the Cohort
Group Definition Based on Myopia Severity Affected (A) Unaffected (N) Unknown (U) Total
High-grade myopia SPH Data: A  5 D, N  0.49 D,
U others
628 368 395 1391
SE Data: A  5 D, N  0.49 D,
U others
580 433 378 1391
Any myopia SPH Data: A  0.5 D, N  0 D, 0.5
D  U  0 D
1023 341 27 1391
SE Data: A  0.5 D, N  0 D, 0.5
D  U  0 D
958 391 42 1391
TABLE 2. Clinical Information Data
High-Grade Myopia Any Myopia
Affected (A) Unaffected (N) Unknown (U) Affected (A) Unaffected (N) Unknown (U)
Sample size by SPH 628 368 395 1023 341 27
Age at examination, y 43.47  20.43 (93) 45  20.47 (55) 43.54  21.49 (69) 43.50  20.83 (162) 44.56  20.11 (48) 48  24.34 (7)
Sphere OD, D 9.59  4.6 (624) 0.74  1.29 (242) 2.04  1.42 (394) 6.67  5.22 (1018) 0.85  1.33 (215) 0.13  0.188 (27)
Sphere OS, D 9.54  4.37 (625) 0.76  1.58 (241) 2.04  1.42 (389) 6.66  5.07 (1014) 0.81  1.44 (215) 0.33  2.44 (26)
Cylinder OD, D 1.02  1.06 (550) 0.77  0.98 (284) 0.81  0.94 (344) 0.94  1.02 (894) 0.79  1.0 (262) 0.55  0.62 (22)
Cylinder OS, D 0.99  1.01 (547) 0.91  0.94 (285) 0.80  0.86 (342) 0.92  0.96 (889) 0.88  0.95 (262) 0.70  0.82 (23)
Numbers in parentheses denote the number of subjects providing the data.
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myopia development is not known, the finding that insulin and
IGF-1 promote ocular axial elongation in the chick model of
myopia make IGF-1 an obvious candidate for further investiga-
tions in both human and animal studies.
Hypothesis-driven candidate gene association studies have been
successfully used to identify causative genes in other diseases. Ge-
netic association studies have recently generatedmuch interest in the
field of myopia genetics, and it is important to be cautious regarding
potential false-positive findings, although this line of research is still
relatively young. Validation and replication of findings is important,
the lack of which can be due to several factors, from publication bias
to interstudy heterogeneity. Careful study design and analyses play an
important role in avoiding this problem and in making cautious yet
meaningful interpretations. In thepresent study,weused an effective
SNP selection strategy, definitive ascertainment criteria, and pheno-
type classification to perform a comprehensive search of markers
within the IGF-1 gene that may be associated with myopia. Rigorous
multiple-correction criteria were applied that pinpointed the associ-
ation of rs6214 with myopia.
In summary, we found that the IGF-1 gene polymorphisms
were genetically associated with high-grade myopia in a Cau-
casian family-based dataset. The current findings, along with
the evidence that IGF-1 was located within a myopia suscep-
tibility locus and its direct involvement in myopia induction in
an animal model, warrant further studies on its role in myopia.
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